Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Not Just Herceptin Biosimilar: Additional 12 Drugs Set For EU Marketing Approval After CHMP Nod

Sep 15 2017

• By Maureen Kenny

3d render of Europe map Earth globe

Related Content

CHMP OKs First EU Biosimilar Herceptin, And Another Version Of Humira

Sep 15 2017

Bold Move To Embed Biosimilar Switching Aims To Bring Savings Of Up To £300m For NHS England

Sep 15 2017

‘Surprised and Disappointed’ Santhera To Fight EU’s DMD Rejection

Sep 15 2017

Santhera Hopeful On EU DMD Indication Extension

Sep 12 2017

New Treatments For Psoriasis, Ovarian Cancer And MS Seeking CHMP Thumbs Up This Week

Sep 13 2017

Ocrevus Launching Quickly Even After Manufacturing Worries Delayed US Approval

Mar 30 2017

AB Science Asks For Re-examination After EMA Rejects Masitinib For Mastocytosis

May 22 2017

GSK's COPD Triple Combo To Challenge Chiesi's Trimbow In EU

Sep 13 2017

Tesaro Pumped As PARP Inhibitor Zejula Gets CHMP Nod

Sep 15 2017

Genentech's Ocrevus Manufacturing Process Still A Work In Progress

Jun 15 2017

Related Companies

Samsung Bioepis Co., Ltd.

Roche Holding AG

Johnson & Johnson

Tesaro, Inc.

GSK plc

AB Science S.A.

XBiotech, Inc.

Helsinn Healthcare SA

Santhera Pharmaceuticals

Grifols, S.A.

Mundipharma International Limited

Boehringer Ingelheim GmbH

AB Science S.A.

XBiotech, Inc.

Helsinn Healthcare SA

Additional Topics

Europe Approvals Regulation Drug Review BioPharmaceutical

More from Europe

More from Geography

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window